Gattefossé | Inquire | Solubilizer, Bioavailability enhancer, Water insoluble surfactant for SELF, Solubilizer for actives, W/O surfactant | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Co-solvent in capsule filling, Inhalation products, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | Solubilizer, Bioavailability enhancer, Co-solvent in capsule filling, Inhalation products, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | | |
Gattefossé | Tablet Lubricant, Lipid Matrix for Sustained Release, Coating for Protection and Taste Masking. Oral Solid Dosage forms in Direct Compression, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization, Supercritical Fluid Extraction, Viscosity modification, Wet Granulation, Solid Lipid Nanoparticles, Nano Lipid Carriers | Tablet Lubricant, Lipid Matrix for Sustained Release, Coating for Protection and Taste Masking. Oral Solid Dosage forms in Direct Compression, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization, Supercritical Fluid Extrac | | |
Gattefossé | Lubricant and wetting agent in fast-dissolving and effervescent tablets. | Lubricant for effervescent, chewable and fast dissolving tablets | | |
Gattefossé | Modified release matrix former for capsule. Coating agent for taste masking. Consistency agent. | Semi-solid vehicle, Non-ionic thickener for emulsions | | |
Gattefossé | Vehicle to suspend pharmaceutical ingredients in soft gelatin capsule. Good dispersibility in aqueous fluid. High drug load achievable. | Oil carrier, Consistency agent | | |
Gattefossé | Emulsifier for difficult-to-formulate APIs, API combinations, anhydrous emulsion. Associate with Emulcire™ 61 WL2659 to enhance sensorial and texture properties. | Non-ionic O/W emulsifier for difficult actives, alcoholic extracts, polar lipids, high heat stability and pH range of 3-12 | | |
Gattefossé | Matrix-forming agent for protection of APIs sensitive to oxidation, humidity, or light. Consistency agent in oral and topical formulations. | Vehicle, Matrix former, Sustained release agent, Multiparticulates | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Surfactant, for Solid Dispersions and SMEDDS in Capsule filling, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization | Solubilizer, Bioavailability enhancer, Surfactant, for Solid Dispersions and SMEDDS in Capsule filling, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Surfactant, for Solid Dispersions and SMEDDS in Capsule filling, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization | Solubilizer, Bioavailability enhancer, Surfactant, for Solid Dispersions and SMEDDS in Capsule filling, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization | | |
Gattefossé | Solubilizer for poorly-soluble APIs and bioavailability enhancer. Single excipient formulation system: self-emulsifies in aqueous fluid into coarse emulsion—LFCS Type III (SMEDDS). Modulation of drug release. Lipid binder in melt processes. | Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Matrix for modified release, Multiparticulates | | |
Gattefossé | Oily phase for topical formulations. Oily vehicle and solubilizer for solutions. | Oily vehicle, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions | | |
Gattefossé | Oily vehicle in LFCS Type I, Type II (SEDDS), and Type III formulations (SMEDDS). Oil phase for topical formulations. Oily vehicle and solubilizer for solutions (parenteral, auricular). | Oily vehicle, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions, Penetration enhancer | | |
Gattefossé | Solubilizer for poorly-soluble API and bioavailability enhancer Single excipient formulation system: self-emulsifies in aqueous fluid into emulsion – LFCS type II (SEDDS) Combine with Labrasol®ALF or Gelucire® 44/14 for LFCS Type III (SMEDDS) Co-emulsifier in topical formulations often associated with Tefose® 63 in antifungal cream | Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions | | |
Gattefossé | Solubilizer for poorly-soluble APIs and bioavailability enhancer. Single excipient formulation system: self-emulsifies in aqueous fluid into emulsion—LFCS Type II (SEDDS). Combine with Labrasol® ALF or Gelucire® 44/14 for LFCS Type III (SMEDDS). | Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer | Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | | |
Gattefossé | Solubilizer and O/W surfactant for microemulsion. Able to form light foams with pump device (no gas required). | Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Topical penetration/permeation enhancer | | |
Gattefossé | Solubilizer for poorly-soluble APIs and bioavailability enhancer. Single excipient formulation system: self-emulsifies in aqueous fluid into microemulsion—LFCS Type III (SMEDDS). High purity guaranteed for stability and capsule compatibility. | Guaranteed for low aldehyde levels. Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Topical penetration/permeation enhancer | | |
Gattefossé | Solubilizer, Bioavailability enhancer, Co-solvent in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | Solubilizer, Bioavailability enhancer, Co-solvent in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid | | |
Gattefossé | Solubilizer for poorly-soluble APIs and bioavailability enhancer. Cosurfactant in LFCS Type II (SEDDS) and Type III (SMEDDS) formulations. Solubilizer and cosurfactant for microemulsion in topical formulation. | Water insoluble cosurfactant, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions, Penetration enhancer | | |
Gattefossé | Solubilizer for lipophilic API and bioavailability enhancer. Oily vehicle for LFCS Type I (oily), Type II (SEDDS) and Type III (SMEDDS), associated with lymphatic absorption. | Oily vehicle, Solubilizer, Bioavailability enhancer, Component of SELF and microemulsions | | |
Gattefossé | Consistency agent for oily phase in topical formulations. Stability-improving agent | Non-ionic consistency/thickening agent, Stabilizer for emulsions | | |
Gattefossé | Good mechanical resistance. Enhanced spreadability of the formulation for vaginal delivery. | Unique blends with varying consistency and wetting properties adapted for vaginal pessaries | | |
Gattefossé | Enables fast-melting at normal temperature of the vaginal cavity. | Unique blends with varying consistency and wetting properties adapted for vaginal pessaries | | |
Gattefossé | Solubilizer for lipophilic APIs and bioavailability enhancer. Oily vehicle containing long-chain fatty acids (C18:2) for LFCS Type I (oily), Type II (SEDDS), and Type III (SMEDDS), associated with lymphatic absorption. Oily vehicle for topical formulations. | Oily vehicle, Solubilizer, Bioavailability enhancer, Component of SELF | | |
Gattefossé | PEG-free W/O emulsifier for topical formulations Ideal for heat-sensitive API Stabilizes and improves sensorial and texture properties | W/O emulsifier for lotions and creams, Excellent for dispersions and apolar oils, Allows hot or cold process | | |
Gattefossé | Lipid Matrix for Sustained Release, Coating for Protection and Taste Masking. Oral Solid Dosage forms in Direct Compression, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization, Supercritical Fluid Extraction, Viscosity modification, Wet Granulation, Solid Lipid Nanoparticles, Nano Lipid Carriers | Lipid Matrix for Sustained Release, Coating for Protection and Taste Masking. Oral Solid Dosage forms in Direct Compression, Dry Granulation, Film Coating, Hot Melt Extrusion, Roller Compaction, Spheronization, Supercritical Fluid Extraction, Viscosity mo | | |
Gattefossé | Emulsifier for anhydrous topical formulations. Emulsifier for difficult-to-formulate emulsions (solvents and large oily phase). Stabilizes and improves sensorial and texture properties. | Inquire | | |
Gattefossé | Inquire | Universal bases for a wide range of manufacturing needs for suppositories and pessaries, compatible with many actives | | |
Gattefossé | Inquire | Non-ionic O/W emulsifier for topical and vaginal creams, High mucosal tolerance, Low-energy, one-pot processing | | |
Gattefossé | High purity solvent for all types of dosage forms, capsules, Injectables, inhalation products, Co-solvent in SMEDDS, solutions, suspensions, Topical Penetration and Permeation enhancer | High purity solvent for all types of dosage forms, capsules, Injectables, inhalation products, Co-solvent in SMEDDS, solutions, suspensions, Topical Penetration and Permeation enhancer | | |